Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection in vivo
By
Alexandra Schäfer,
Frauke Muecksch,
Julio C. C. Lorenzi,
Sarah R. Leist,
Melissa Cipolla,
Stylianos Bournazos,
Fabian Schmidt,
Anna Gazumyan,
Ralph Baric,
Davide F. Robbiani,
Theodora Hatziioannou,
Jeffrey V. Ravetch,
Paul D D Bieniasz,
Michel C. Nussenzweig,
Timothy P. Sheahan
Posted 15 Sep 2020
bioRxiv DOI: 10.1101/2020.09.15.298067
SARS-CoV-2, the causative agent of COVID-19, is responsible for over 24 million infections and 800,000 deaths since its emergence in December 2019. There are few therapeutic options and no approved vaccines. Here we examine the properties of highly potent human monoclonal antibodies (hu-mAbs) in a mouse adapted model of SARS-CoV-2 infection (SARS-CoV-2 MA). In vitro antibody neutralization potency did not uniformly correlate with in vivo activity, and some hu-mAbs were more potent in combination in vivo . Analysis of antibody Fc regions revealed that binding to activating Fc receptors is essential for optimal protection against SARS-CoV-2 MA. The data indicate that hu-mAb protective activity is dependent on intact effector function and that in vivo testing is required to establish optimal hu-mAb combinations for COVID-19 prevention. ### Competing Interest Statement The authors have declared no competing interest.
Download data
- Downloaded 1,317 times
- Download rankings, all-time:
- Site-wide: 12,966
- In microbiology: 727
- Year to date:
- Site-wide: 5,151
- Since beginning of last month:
- Site-wide: 5,151
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!